Regenacy Pharmaceuticals Email Formats

Biotechnology Research • 303 Wyman St, Waltham, United States • 1-10 Employees

Key Contact at Regenacy Pharmaceuticals

Michael Huang

Member Board Of Directors

Company overview

Headquarters	303 Wyman St, Waltham, Massachusetts 02451, US
Phone number	+16174155030
Website	regenacy.com
SIC	283
Founded	2016
Employees	1-10
Socials

About Regenacy Pharmaceuticals

Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function. Our lead compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6 with first-in-class potential, currently positioned to enter Phase 2 clinical trials. Our investigation of ricolinostat for diabetic, chemotherapy-induced and inherited peripheral neuropathies is based on compelling proof-of-concept preclinical studies demonstrating restoration of normal nerve function. We were founded in December 2016 following the acquisition of Acetylon Pharmaceuticals by Celgene. Regenacy received exclusive rights to ricolinostat, a clinical stage, orally bioavailable, HDAC6 selective inhibitor, for a range of non-cancer disease indications. We also have a unique and proprietary portfolio of selective HDAC1,2 inhibitors with potential for treating cancer, hemoglobinopathies, and cognitive dysfunction.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Director

Employees by Department

Regenacy Pharmaceuticals has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Regenacy Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-09-15	5	$9,300,000

Funding Insights

$9,300,000

Total funding amount

$9,300,000

Most recent funding amount

Number of funding rounds

Regenacy Pharmaceuticals Tech Stack

Discover the technologies and tools that power Regenacy Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Stripe

Payment processors

Squarespace Commerce

Ecommerce

reCAPTCHA

Security

GoDaddy

Hosting

Nginx

Reverse proxies

GoDaddy Domain Parking

Domain parking

HSTS

Security

React

JavaScript frameworks

core-js

JavaScript libraries

OpenResty

Web servers

Frequently asked questions

Regenacy Pharmaceuticals is located in 303 Wyman St, Waltham, US.

You can reach Regenacy Pharmaceuticals at +16174155030.

Regenacy Pharmaceuticals was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Regenacy Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Regenacy Pharmaceuticals has raised a total of $9,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Regenacy Pharmaceuticals

Michael Huang

Member Board Of Directors

4.8

40,000 users